2748. Ceftolozane/tazobactam For the Treatment of Cystic Fibrosis Patients: Results from a French Prospective Cohort Study
Xavier Bourge(MSD (France)), Pierre‐Régis Burgel(Inserm), David Boutoille(Inserm), Carole Mackosso(MSD (France)), Jean‐François Timsit(Université Claude Bernard Lyon 1), Linsay Monteiro Tavares(Inserm), Bernard Castan, Brune Akrich(MSD (France)), Fabrice Ruiz(Monal Group (France)), Joy Mootien(Centre Hospitalier de Mulhouse), Isabelle Brassac
Cited by 0
Related Papers
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797